Background: Mediastinoscopy is the gold standard procedure for the pathological
staging and diagnosis of mediastinal diseases. The aim of the study is to
describe the significance of anterior cervical Mediastinoscopy in evaluating
patients with mediastinal lymphadenopathy and lung parenchymal disease. Material
and Methods: From January 2014 until June 2017 we conducted a retrospective
study of 52 consecutive patients with mediastinal lymphadenopathy and lung
parenchymal disease who underwent anterior cervical Mediastinoscopy. The main
indications for cervical Mediastinoscopy were isolated mediastinal
lymphadenopathy, undetermined lung mass with mediastinal lymphadenopathy, and
the clinical staging of patients with lung cancer. Results: The study
subjects consisted of 37 men and 15 women, aged 13 to 87 (mean age 50.8). Eight
patients had mediastinoscopy for staging lung cancer, 27 patients had
mediastinoscopy to diagnose isolated mediastinal lymphadenopathy, and 17
patients had mediastinoscopy for an undetermined lung parenchymal mass. Among
the patients with isolated mediastinal lymphadenopathy, sarcoidosis was
diagnosed in 6, tuberculosis in 9, reactive lymph nodes in 4, metastasis in 5
and lymphoma in 3. Lymph node metastasis (N2, N3) was found in 5 patients with
lung cancer. There was no surgical-related mortality or morbidity. Conclusions: Mediastinoscopy is a safe and reliable procedure in diagnosing mediastinal
diseases and is still the first choice among the investigative modalities in
the clinical staging of bronchogenic carcinoma.
Van Schil, P.E.Y., Van Hee, R.H.G.G. and Schools, E.L.G. (1989) The Value of Mediastinoscopy in Preoperative Staging of Bronchogenic Carcinoma. The Journal of Thoracic and Cardiovascular Surgery, 97, 240-244.
Gdeedo, A., Van Schill, P., Corthouts, B., et al. (1997) Prospective Evaluation of Computed Tomography and Mediastinoscopy in Mediastinal Lymph Node Staging European Respiratory Journal, 10, 1547-1551.
Funatsu, T., Matsubara, Y., Hatakenaka, R., et al. (1992) The Role of Mediastinoscopic Biopsy in Preoperative Assessment of Lung Cancer. The Journal of Thoracic and Cardiovascular Surgery, 104, 1688-1695.
De Leyn, P., Vansteenkiste, J., Cuypers, P., et al. (1997) Role of Cervical Mediastinoscopy in Staging of Non-Small Cell Lung Cancer without Enlarged Mediastinal Lymph Nodes on CT Scan. European Journal of Cardio-Thoracic Surgery, 12, 706-712. https://doi.org/10.1016/S1010-7940(97)00253-4
Dillemans, B., Deneffe, G., Verschakelen, J. and Decramer, M. (1994) Value of Computed Tomography and Mediastinoscopy in Preoperative Evaluation of Mediastinal Nodes in Non-Small Cell Lung Cancer. European Journal of Cardio-Thoracic Surgery, 8, 37-42. https://doi.org/10.1016/1010-7940(94)90131-7
Yasufuku, K., Pierre, A., Darling, G., de Perrot, M., Waddell, T., Johnston, M., et al. (2011) A Prospective Controlled Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Compared with Mediastinoscopy for Mediastinal lymph Node Staging of Lung Cancer. The Journal of Thoracic and Cardiovascular Surgery, 142, 1393-1400. https://doi.org/10.1016/j.jtcvs.2011.08.037
Steinert, H.C., Hauser, M., Allemann, F., et al. (1997) Non-Small Cell Lung Cancer: Nodal Staging with FDG-PET versus CT with Correlative Lymph Node Mapping and Sampling. Radiology, 202, 441-446.
Sasaki, M., Ichiya, Y., Kuwabara, Y., et al. (1996) The Usefulness of FDG Positron Emission Tomography for the Detection of Mediastinal Lymph Node Metastases in Patients with Non-Small Cell Lung Cancer: A Comparative Study with X-Ray Computed Tomography. European Journal of Nuclear Medicine, 23, 741-747.
de Langen, A.J., Raijmakers, P., Riphagen, I., Paul, M.A. and Hoekstra, O.S. (2006) The Size of Mediastinal Lymph Nodes and Its Relation with Metastatic Involvement: A Meta-Analysis. European Journal of Cardio-Thoracic Surgery, 29, 26-29.
De Leyn, P., Stroobants, S., De Wever, W., Lerut, T., Coosemans, W., Decker, G., et al. (2006) Prospective Comparative Study of Integrated Positron Emission Tomography-Computed Tomography Scan Compared with Remediastinoscopy in the Assessment of Residual Mediastinal Lymph Node Disease after Induction Chemotherapy for Mediastinoscopy-Proven Stage IIIA-N2 Non-Small-Cell Lung Cancer: A Leuven Lung Cancer Group Study. Journal of Clinical Oncology, 24, 3333-3339.
Metin, M., Citak, N., Sayar, A., Pekcolaklar, A., Melek, H., Kok, A., et al. (2011) The Role of Extended Cervical Mediastinoscopy in Stagin of Non-Small Cell Lung Cancer of the Left Lung and a Comparison with Integrated Positron Emission Tomography and Computed Tomography: Does Integrated Positron Emission Tomograpy and Computed Tomography Reduce the Need for Invasive Procedures? Journal of Thoracic Oncology, 6, 1713-1719.
De Leyn, P., Schoonooghe, P., Deneffe, G., Van Raemdonck, D., Coosemans, W., Vansteenkiste, J. and Lerut, T. (1996) Surgery for Non-Small Cell Lung Cancer with Unsuspected Metastasis to Ipsilateral Mediastinal or Subcarinal Nodes (N2 Disease). European Journal of Cardio-Thoracic Surgery, 10, 649-655.
De Leyn, P., Lardinois, D., Van Schil, P.E., Rami-Porta, R., Passlick, B., Zielinski, M, et al. (2007) ESTS Guidelines for Preoperative Lymph Node Staging for Non-Small Cell Lung Cancer. European Journal of Cardio-Thoracic Surgery, 32, 1-8.